Clear Trial Podcast series: Trends in Assessing Internal and Outsourced Clinical Trial Costs and Resource Demand

Dec 01, 2010
By Pharmaceutical Executive
rss itunes google yahoo
Click icon to automatically deliver podcasts to your iTunes or rich media player.

Trends in Assessing Internal and Outsourced Clinical Trial Costs and Resource Demand
Event Overview:
Join Reid Paul, Editor in Chief of Pharmaceutical Representative, Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Andy Grygiel, Vice President of Marketing and Product Management at ClearTrial, for Parts 1 and 2 of this podcast series as we discuss recent Tufts research on assessing clinical trial costs and resource demand. In Part 3 of the series, Molly Blake-Michaels, Director, Clinical Services at ClearTrial, examines the pros and cons of the most widely used clinical trial forecasting and budgeting methods in use today by biopharmaceutical and medical device companies.

Sponsored By ClearTrial

Episode 1 : A discussion of recent Tufts CSDD research on assessing clinical trial costs.

Click Here to Listen>>>

Episode 2: Further insight into the results of the Tufts CSDD research.

Click Here to Listen>>>

Episode 3: An examination of the pros and cons of clinical trial forecasting and budgeting methods in use today by biopharmaceutical and medical device companies.

Click Here to Listen>>>

line
 
Sponsored By
ClearTrial provides Clinical Trial Operations software that makes the planning, forecasting, and tracking of clinical project and financial performance faster and more accurate.